Suma Kaza, T Jaya Mastan Rao, Anupama Mikkilineni, G Venkata Ratnam, D Ranga Rao
Citation Information :
Kaza S, Rao TJ, Mikkilineni A, Ratnam GV, Rao DR. Ki-67 Index in Salivary Gland Neoplasms. Int J Phonosurg Laryngol 2016; 6 (1):1-7.
Proliferation markers in Tumors: Interpretation and clinical value. J Clin Pathol 1998 Oct;51(10):716-724.
The prognosis of specific types of salivary gland tumors. Cancer 1984 Oct;54(8):1620-1624.
Prognostic significance of p27 and Ki-67 expression in mucoepidermoid carcinoma of the intraoral minor salivary gland. Mod Pathol 2001 Oct;14(10):1008-1014.
Prognostic relevance of cell proliferation in major salivary gland carcinomas Acta Otorhinolaryngol Ital 2005 Jun;25(3):161-168.
Tumors of the salivary glands. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. Pathology and genetics of head & neck tumors. Lyon: IARC Press; 2005. p. 212-283.
Comparison staining of mitotic figures by haematoxylin and eosin and crystal violet stains in oral epithelial dysplasia and squamous cell carcinoma. Indian J Dent Res 2007 Jul-Sep;18(3):101-105.
Reproducibility of mitosis counting in 2,469 breast carcinoma specimens: results from the multicenter morphometric mammary carcinoma project. Hum Pathol 1992 Jun;23(6):603-607.
Methodologic aspects of a standardized evaluation of mitotic activity in tumor tissues. Pathologe 1997 Nov;18(6):439-444.
Immunohistochemical evaluation with ki-67: an application to salivary gland tumors. J Laryngol Otol 1992 Jan;106(1):35-38.
Salivary gland tumors. In: Fletcher CDM, editors. Diagnostic histopathology of tumors. 2nd ed. Chap 7, Vol. 1 Churchill Livingstone; An Imprint of Elsevier Science Limited, Philadelphia, USA. 2003. p. 231-311.
Ki-67 proliferation rate as a prognostic marker in major salivary gland carcinomas. Ann Otol Rhinol Laryngol 2010 Oct;119(10):677-683.
Proliferative potential in benign mixed salivary gland tumors and its value in primary and recurrent neoplasms. Stomatologija 2011;13(2):35-41.
Mixed tumor, polymorphous low grade adenocarcinoma and adenoidcystic carcinoma of the salivary gland: Pathogenic implications and differential diagnosis by Ki-67(MIB-1), BCL2 and S100 immunohistochemistry. Appl Immunohistochem 1997 Mar;5(1):8-16.
Assessment of proliferative activity using the MIB1 antibody help to distinguish polymorphous low grade adenocarcinoma from adenoid cystic carcinoma of salivary glands. Pathol Res Pract. Pathol Res Pract 1997;193(10):695-703.
Basaloid monomorphic adenomas. Ann Otol Rhinol Laryngol 1991 Aug;100(8):687-690.
Salivary gland malignant myoepithelioma: a clinicopathologic and immunohistochemical study of 10 cases. Cancer 1998 Oct 1;83(7):1292-1299.
Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: Clinicopathological study using MIB1 antibody in paraffin sections. Hum Pathol 1994 Sep;25(9):929-935.
Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: Recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry. Histopathology 2005 Feb;46(2):144-152.
Major and minor salivary glands. In: Silverberg SG, editor. Vol. I: Silverberg's principle and practice of surgical and cytopathology. New York (NY): Churchill Livingstone; 2006. p. 1203-1277.
